LifeStance Health Long Term Debt 2020-2025 | LFST
LifeStance Health long term debt from 2020 to 2025. Long term debt can be defined as the sum of all long term debt fields.
|
LifeStance Health Annual Long Term Debt (Millions of US $) |
|
|---|---|
| 2024 | $280 |
| 2023 | $280 |
| 2022 | $225 |
| 2021 | $157 |
| 2020 | $363 |
| 2019 | $79 |
|
LifeStance Health Quarterly Long Term Debt (Millions of US $) |
|
|---|---|
| 2025-09-30 | $269 |
| 2025-06-30 | $273 |
| 2025-03-31 | $276 |
| 2024-12-31 | $280 |
| 2024-09-30 | $279 |
| 2024-06-30 | $279 |
| 2024-03-31 | $280 |
| 2023-12-31 | $280 |
| 2023-09-30 | $248 |
| 2023-06-30 | $249 |
| 2023-03-31 | $225 |
| 2022-12-31 | $225 |
| 2022-09-30 | $212 |
| 2022-06-30 | $203 |
| 2022-03-31 | $177 |
| 2021-12-31 | $157 |
| 2021-09-30 | $157 |
| 2021-06-30 | $157 |
| 2021-03-31 | $387 |
| 2020-12-31 | $363 |
| 2020-09-30 | |
| 2020-06-30 | |
| 2020-03-31 | |
| 2019-12-31 | $79 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $2.793B | $1.251B |
| LifeStance Health Group Inc. is provider of virtual and in-person outpatient mental health care for children, adolescents and adults of mental health conditions. LifeStance Health Group Inc. is based in SCOTTSDALE, Ariz. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quest Diagnostics (DGX) | United States | $21.019B | 19.56 |
| Elanco Animal Health (ELAN) | United States | $12.004B | 25.17 |
| Encompass Health (EHC) | United States | $9.944B | 19.12 |
| DaVita (DVA) | United States | $7.337B | 10.71 |
| Chemed (CHE) | United States | $6.368B | 22.37 |
| Option Care Health (OPCH) | United States | $5.681B | 24.18 |
| RadNet (RDNT) | United States | $5.435B | 185.40 |
| Addus HomeCare (ADUS) | United States | $2.009B | 20.74 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.907B | 24.03 |
| Astrana Health (ASTH) | United States | $1.475B | 137.95 |
| U.S Physical Therapy (USPH) | United States | $1.294B | 32.74 |
| Pennant (PNTG) | United States | $1.014B | 33.68 |
| Daxor (DXR) | United States | $0.065B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.049B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |